Sevoflurane is an ether inhalation anesthetic agent used to induce and maintain general anesthesia. It is a volatile, non-flammable compound with a low solubility profile and blood/gas partition coefficient. Sevoflurane was patented in 1972, was approved for clinical use in Japan in 1990, and approved by the FDA in 1996. Sevoflurane is three times more poten...
Sevoflurane is used for the induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.
Sykehuset i Vestfold HF, Tonsberg, Norway
University Hospital Ghent, Ghent, Belgium
Technische Universität München, Klinikum rechts der Isar, Department of Anesthesiology, Munich, Bavaria, Germany
Cleveland Clinic, Cleveland, Ohio, United States
General Hospital Dubrovnik, Dubrovnik, Croatia
University Hospital of Zurich, Zurich, Switzerland
University Hospital of Zurich, Zurich, Switzerland
Karolinska University Hospital Solna, Cardiothoracic Intensive Care Unit, Stockholm, Sweden
University Hospital Dubrava, Zagreb, Croatia
Klinik fuer Anaesthesiologie am Universitätsklinikum Schleswig Holstein, Campus Luebeck, Lubeck, Germany
Klinik fuer Anaesthesiologie der Ludwigs-Maximilians-Universitaet Muenchen, Munich, Germany
Krankenhaus Friedrichshafen, Friedrichshafen, Germany
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.